Literature DB >> 20670829

Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.

John P Miller1, Jennifer Holcomb, Ismael Al-Ramahi, Maria de Haro, Juliette Gafni, Ningzhe Zhang, Eugene Kim, Mario Sanhueza, Cameron Torcassi, Seung Kwak, Juan Botas, Robert E Hughes, Lisa M Ellerby.   

Abstract

Proteolytic cleavage of huntingtin (Htt) is known to be a key event in the pathogenesis of Huntington's disease (HD). Our understanding of proteolytic processing of Htt has thus far focused on the protease families-caspases and calpains. Identifying critical proteases involved in Htt proteolysis and toxicity using an unbiased approach has not been reported. To accomplish this, we designed a high-throughput western blot-based screen to examine the generation of the smallest N-terminal polyglutamine-containing Htt fragment. We screened 514 siRNAs targeting the repertoire of human protease genes. This screen identified 11 proteases that, when inhibited, reduced Htt fragment accumulation. Three of these belonged to the matrix metalloproteinase (MMP) family. One family member, MMP-10, directly cleaves Htt and prevents cell death when knocked down in striatal Hdh(111Q/111Q) cells. Correspondingly, MMPs are activated in HD mouse models, and loss of function of Drosophila homologs of MMPs suppresses Htt-induced neuronal dysfunction in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670829      PMCID: PMC3098887          DOI: 10.1016/j.neuron.2010.06.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  61 in total

1.  Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.

Authors:  Yuji Tanaka; Shuichi Igarashi; Masayuki Nakamura; Juliette Gafni; Cameron Torcassi; Gabrielle Schilling; Danielle Crippen; Jonathan D Wood; Akira Sawa; Nancy A Jenkins; Neal G Copeland; David R Borchelt; Christopher A Ross; Lisa M Ellerby
Journal:  Neurobiol Dis       Date:  2005-09-16       Impact factor: 5.996

2.  Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.

Authors:  Zhengkuan Mao; Yeun Su Choo; Mathieu Lesort
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

Review 3.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

4.  Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin homologues SPPL2b and SPPL3.

Authors:  Peter Krawitz; Christof Haffner; Regina Fluhrer; Harald Steiner; Bettina Schmid; Christian Haass
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

5.  Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.

Authors:  Rona K Graham; Yu Deng; Elizabeth J Slow; Brendan Haigh; Nagat Bissada; Ge Lu; Jacqueline Pearson; Jacqueline Shehadeh; Lisa Bertram; Zoe Murphy; Simon C Warby; Crystal N Doty; Sophie Roy; Cheryl L Wellington; Blair R Leavitt; Lynn A Raymond; Donald W Nicholson; Michael R Hayden
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

6.  Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain.

Authors:  Z Cai; S Lin; L-W Fan; Y Pang; P G Rhodes
Journal:  Neuroscience       Date:  2005-11-14       Impact factor: 3.590

7.  Lysosomal proteases are involved in generation of N-terminal huntingtin fragments.

Authors:  Yun J Kim; Ellen Sapp; Benjamin G Cuiffo; Lindsay Sobin; Jennifer Yoder; Kimberly B Kegel; Zheng-Hong Qin; Peter Detloff; Neil Aronin; Marian DiFiglia
Journal:  Neurobiol Dis       Date:  2006-01-19       Impact factor: 5.996

8.  Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function.

Authors:  Anat Yanai; Kun Huang; Rujun Kang; Roshni R Singaraja; Pamela Arstikaitis; Lu Gan; Paul C Orban; Asher Mullard; Catherine M Cowan; Lynn A Raymond; Renaldo C Drisdel; William N Green; Brinda Ravikumar; David C Rubinsztein; Alaa El-Husseini; Michael R Hayden
Journal:  Nat Neurosci       Date:  2006-05-14       Impact factor: 24.884

9.  Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.

Authors:  M Kim; H S Lee; G LaForet; C McIntyre; E J Martin; P Chang; T W Kim; M Williams; P H Reddy; D Tagle; F M Boyce; L Won; A Heller; N Aronin; M DiFiglia
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

10.  A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.

Authors:  Zezong Gu; Jiankun Cui; Stephen Brown; Rafael Fridman; Shahriar Mobashery; Alex Y Strongin; Stuart A Lipton
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.709

View more
  84 in total

1.  Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative.

Authors:  Andrew T N Tebbenkamp; Cameron Green; Guilian Xu; Eileen M Denovan-Wright; Aaron C Rising; Susan E Fromholt; Hilda H Brown; Debbie Swing; Ronald J Mandel; Lino Tessarollo; David R Borchelt
Journal:  Hum Mol Genet       Date:  2011-04-22       Impact factor: 6.150

Review 2.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 3.  iPSC-based drug screening for Huntington's disease.

Authors:  Ningzhe Zhang; Barbara J Bailus; Karen L Ring; Lisa M Ellerby
Journal:  Brain Res       Date:  2015-09-30       Impact factor: 3.252

Review 4.  Adult neurogenesis in neurodegenerative diseases.

Authors:  Beate Winner; Jürgen Winkler
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

5.  A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Authors:  Cendrine Tourette; Biao Li; Russell Bell; Shannon O'Hare; Linda S Kaltenbach; Sean D Mooney; Robert E Hughes
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

Review 6.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

7.  Hunting-ton for new proteases: MMPs as the new target?

Authors:  Ashu Johri; M Flint Beal
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

8.  Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

Authors:  Ian H Kratter; Hengameh Zahed; Alice Lau; Andrey S Tsvetkov; Aaron C Daub; Kurt F Weiberth; Xiaofeng Gu; Frédéric Saudou; Sandrine Humbert; X William Yang; Alex Osmand; Joan S Steffan; Eliezer Masliah; Steven Finkbeiner
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

9.  Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.

Authors:  Boxun Lu; Ismael Al-Ramahi; Antonio Valencia; Qiong Wang; Frada Berenshteyn; Haidi Yang; Tatiana Gallego-Flores; Salah Ichcho; Arnaud Lacoste; Marc Hild; Marian Difiglia; Juan Botas; James Palacino
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

10.  Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.

Authors:  Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Journal:  Neuropsychobiology       Date:  2014-02-27       Impact factor: 2.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.